65 related articles for article (PubMed ID: 34232603)
21. Immunohistochemical expression of p16, Ki-67 and p53 in cervical lesions - A systematic review.
Silva DC; Gonçalves AK; Cobucci RN; Mendonça RC; Lima PH; Cavalcanti G
Pathol Res Pract; 2017 Jul; 213(7):723-729. PubMed ID: 28554769
[TBL] [Abstract][Full Text] [Related]
22. Diagnosing Anal Squamous Intraepithelial Lesions With and Without p16: An Interobserver Variability Study.
Krishnamurti U; Mohammad M; Monsrud A; Mosunjac M; Oprea G; Hanley K; Tadros T; Flowers L; Mosunjac M
J Low Genit Tract Dis; 2020 Jan; 24(1):69-74. PubMed ID: 31860579
[TBL] [Abstract][Full Text] [Related]
23. Diagnosing cervical biopsies in adolescents: the use of p16 immunohistochemistry to improve reliability and reproducibility.
Sayed K; Korourian S; Ellison DA; Kozlowski K; Talley L; Horn HV; Simpson P; Parham DM
J Low Genit Tract Dis; 2007 Jul; 11(3):141-6. PubMed ID: 17596758
[TBL] [Abstract][Full Text] [Related]
24. p16 Immunohistochemistry Is Not Always Required For Accurate Diagnosis of Grade 2 Squamous Intraepithelial Lesions.
Sun L; Zhang L; Krigman HR; Hagemann IS
J Low Genit Tract Dis; 2018 Apr; 22(2):104-109. PubMed ID: 29570565
[TBL] [Abstract][Full Text] [Related]
25. Classifying Anal Intraepithelial Neoplasia 2 Based on LAST Recommendations.
Liu Y; McCluggage WG; Darragh TM; Zheng W; Roberts JM; Park KJ; Hui P; Blakely M; Sigel K; Gaisa MM
Am J Clin Pathol; 2021 May; 155(6):845-852. PubMed ID: 33210115
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of p16INK4a, minichromosome maintenance protein 2, DNA topoisomerase IIalpha, ProEX C, and p16INK4a/ProEX C in cervical squamous intraepithelial lesions.
Shi J; Liu H; Wilkerson M; Huang Y; Meschter S; Dupree W; Schuerch C; Lin F
Hum Pathol; 2007 Sep; 38(9):1335-44. PubMed ID: 17512033
[TBL] [Abstract][Full Text] [Related]
27. HPV E6/E7 mRNA In Situ Hybridization in the Diagnosis of Cervical Low-grade Squamous Intraepithelial Lesions (LSIL).
Mills AM; Coppock JD; Willis BC; Stoler MH
Am J Surg Pathol; 2018 Feb; 42(2):192-200. PubMed ID: 29112014
[TBL] [Abstract][Full Text] [Related]
28. The LAST guidelines in clinical practice: implementing recommendations for p16 use.
Clinton LK; Miyazaki K; Ayabe A; Davis J; Tauchi-Nishi P; Shimizu D
Am J Clin Pathol; 2015 Dec; 144(6):844-9. PubMed ID: 26572990
[TBL] [Abstract][Full Text] [Related]
29. Interobserver reproducibility of cervical histology interpretation with and without p16 immunohistochemistry.
Tao AS; Zuna R; Darragh TM; Grabe N; Lahrmann B; Clarke MA; Wentzensen N
Am J Clin Pathol; 2024 Mar; ():. PubMed ID: 38527169
[TBL] [Abstract][Full Text] [Related]
30. Usefulness of liquid-based cytology specimens for the immunocytochemical study of p16 expression and human papillomavirus testing: a comparative study using simultaneously sampled histology materials.
Yoshida T; Fukuda T; Sano T; Kanuma T; Owada N; Nakajima T
Cancer; 2004 Apr; 102(2):100-8. PubMed ID: 15098254
[TBL] [Abstract][Full Text] [Related]
31. Stratified mucin-producing intraepithelial lesion with invasive carcinoma: 12 cases with immunohistochemical and ultrastructural findings.
Onishi J; Sato Y; Sawaguchi A; Yamashita A; Maekawa K; Sameshima H; Asada Y
Hum Pathol; 2016 Sep; 55():174-81. PubMed ID: 27237368
[TBL] [Abstract][Full Text] [Related]
32. Tissue-based Immunohistochemical Biomarker Accuracy in the Diagnosis of Malignant Glandular Lesions of the Uterine Cervix: A Systematic Review of the Literature and Meta-Analysis.
Lee S; Rose MS; Sahasrabuddhe VV; Zhao R; Duggan MA
Int J Gynecol Pathol; 2017 Jul; 36(4):310-322. PubMed ID: 27801764
[TBL] [Abstract][Full Text] [Related]
33. Polish recommendations regarding diagnostics and treatment of cervical squamous intraepithelial lesions according to the CAP/ASCCP guidelines.
Nasierowska-Guttmejer A; Kędzia W; Wojtylak S; Lange D; Rokita W; Jach R; Wielgoś M
Ginekol Pol; 2016; 87(9):670-6. PubMed ID: 27723078
[No Abstract] [Full Text] [Related]
34. "Immunocytochemical expression of P53, PTEN, FAS (CD95), P16INK4A and HPV L1 major capsid proteins in ThinPrep cervical samples with squamous intraepithelial lesions".
Grapsa D; Frangou-Plemenou M; Kondi-Pafiti A; Stergiou E; Nicolopoulou-Stamati P; Patsouris E; Chelidonis G; Athanassiadou P
Diagn Cytopathol; 2014 Jun; 42(6):465-75. PubMed ID: 23729286
[TBL] [Abstract][Full Text] [Related]
35. Protein p16 as a marker of dysplastic and neoplastic alterations in cervical epithelial cells.
Volgareva G; Zavalishina L; Andreeva Y; Frank G; Krutikova E; Golovina D; Bliev A; Spitkovsky D; Ermilova V; Kisseljov F
BMC Cancer; 2004 Aug; 4():58. PubMed ID: 15339339
[TBL] [Abstract][Full Text] [Related]
36. p16 Positive Histologically Bland Squamous Metaplasia of the Cervix: What does It Signify?
Goyal A; Ellenson LH; Pirog EC
Am J Surg Pathol; 2020 Jan; 44(1):129-139. PubMed ID: 31498174
[TBL] [Abstract][Full Text] [Related]
37. A systematic review of p16/Ki-67 immuno-testing for triage of low grade cervical cytology.
Kisser A; Zechmeister-Koss I
BJOG; 2015 Jan; 122(1):64-70. PubMed ID: 25208923
[TBL] [Abstract][Full Text] [Related]
38. Proposed Terminology for Anal Squamous Lesions: Its Application and Interobserver Agreement Among Pathologists in Academic and Community Hospitals.
Roma AA; Liu X; Patil DT; Xie H; Allende D
Am J Clin Pathol; 2017 Jul; 148(1):81-90. PubMed ID: 28605400
[TBL] [Abstract][Full Text] [Related]
39. Histological interpretation of differentiated vulvar intraepithelial neoplasia (dVIN) remains challenging-observations from a bi-national ring-study.
Dasgupta S; de Jonge E; Van Bockstal MR; Wong-Alcala LSM; Wilhelmus S; Makkus LACF; Schelfout K; Van de Vijver KK; Smits S; Marbaix E; Koljenović S; van Kemenade FJ; Ewing-Graham PC
Virchows Arch; 2021 Aug; 479(2):305-315. PubMed ID: 33682013
[TBL] [Abstract][Full Text] [Related]
40. Immunohistochemical detection of p16INK4a in dysplastic lesions of the oral cavity.
Bradley KT; Budnick SD; Logani S
Mod Pathol; 2006 Oct; 19(10):1310-6. PubMed ID: 16799478
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
